DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Desoximetasoneis the generic ingredient in three branded drugs marketed by Actavis Mid Atlantic, Akorn, Cadila, Cosette, Fougera Pharms, Lupin Atlantis, Perrigo New York, Rising, Taro Pharm Inds Ltd, Altana, Glenmark Generics, Novel Labs Inc, Perrigo Israel, Teligent Pharma Inc, Zydus Pharms, and Taro Pharms, and is included in forty NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
Desoximetasone has four patent family members in four countries.
There are seven drug master file entries for desoximetasone. Eighteen suppliers are listed for this compound.
Summary for DESOXIMETASONE
|Drug Master File Entries:||7|
|Suppliers / Packagers:||18|
|Bulk Api Vendors:||43|
|Drug Prices:||Drug price trends for DESOXIMETASONE|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for DESOXIMETASONE|
|DailyMed Link:||DESOXIMETASONE at DailyMed|
Recent Clinical Trials for DESOXIMETASONE
Identify potential brand extensions & 505(b)(2) entrants
|Wake Forest University Health Sciences||Phase 4|
|Siriraj Hospital||Phase 3|
|Siriraj clinical research center||Phase 3|
Pharmacology for DESOXIMETASONE
|Drug Class||Corticosteroid |
|Mechanism of Action||Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for DESOXIMETASONE
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Taro Pharm Inds Ltd||TOPICORT||desoximetasone||CREAM;TOPICAL||073193-001||Nov 30, 1990||AB||RX||No||Yes||Start Trial||Start Trial||Start Trial|
|Perrigo New York||DESOXIMETASONE||desoximetasone||CREAM;TOPICAL||076510-001||Jul 1, 2003||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|Novel Labs Inc||DESOXIMETASONE||desoximetasone||OINTMENT;TOPICAL||206792-001||May 10, 2016||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
|Taro Pharms||TOPICORT||desoximetasone||SPRAY;TOPICAL||204141-001||Apr 11, 2013||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>Patent No.||>Patent Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.